Relaxera is a pharmaceutical company focused on the development of a treatment of the aging heart (Heart Failure with preserved Ejection Fraction – HFpEF) and on protecting pancreatic cells against the glucotoxic effects caused by impaired glucose tolerance. Our pharmaceutical candidate is relaxin-2, a member of the family of insulin-like hormones, which is released into the blood stream during partition and known for its p...
Relaxera is a pharmaceutical company focused on the development of a treatment of the aging heart (Heart Failure with preserved Ejection Fraction – HFpEF) and on protecting pancreatic cells against the glucotoxic effects caused by impaired glucose tolerance. Our pharmaceutical candidate is relaxin-2, a member of the family of insulin-like hormones, which is released into the blood stream during partition and known for its pleiotropic effects in the human body. Relaxera has developed methods for its synthesis in large quantities and is examining its effects on the heart muscle fibres and on the islet cells of pancreas.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.